THE TERRY FOX FOUNDATION in partnership with the Canadian Institutes of Health Research has awarded $27.3 million in new funding to six Canadian research teams to engineer precision medicines for patients whose cancer has relapsed or for whom current treatments are ineffective or non-existent. The Terry Fox Research Institute teams are conducting research into brain,... […]
FDA said it has taken action against 55 tobacco retailers by issuing the first warning letters for selling newly regulated tobacco products, such as e-cigarettes, e-liquids and cigars, to minors. These actions come about a month after FDA began enforcing new federal regulations making it illegal nationwide to sell e-cigarettes, cigars, hookah tobacco, and other... […]
FDA has modified the dosage regimen for nivolumab (Opdivo), sponsored by Bristol-Myers Squibb Co., for the currently approved indications for renal cell carcinoma, metastatic melanoma, and non-small cell lung cancer. The currently approved recommended dosage regimens were modified to 240 mg intravenously (IV) every two weeks. jQuery(document).ready(function(){ jQuery('.people-thumb + p > span.has-red-100-color, .people-thumb + p... […]
THOMAS IMPERIALE, investigator at the Regenstrief Institute, was named the inaugural Lawrence Lumeng Professor in Gastroenterology and Hepatology at Indiana University School of Medicine. Imperiale is a health services researcher and a clinical gastroenterologist. His research focuses on developing and testing screening strategies for colorectal cancer based on risk factors. In addition to the IU... […]
ASHANI WEERATNA, associate professor and program leader in the Tumor Microenvironment and Metastasis Program, was named the Ira Brind Associate Professor at the Wistar Institute. Weeraratna’s primary research focus is how melanoma metastasizes and how changes in the tumor microenvironment might initiate the disease’s spread or make it resistant to treatment. She is also a... […]
LEVI GARRAWAY was named senior vice president, Global Development & Medical Affairs, for Eli Lilly and Co.‘s Oncology business. He will succeed Richard Gaynor, who is retiring, on Jan. 1, 2017. Garraway is an associate professor of medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School, an associate... […]
RUTH BROWNE was named new president and chief executive officer of the Ronald McDonald House. Browne joins Ronald McDonald House New York from the Arthur Ashe Institute for Urban Health, where she served as CEO since 2004. Browne will assume the role on Sept. 19, 2016. Browne will lead the organization throughout its $23.6 million... […]
THE CINCINNATI CHILDREN’S/UC HEALTH PROTON THERAPY CENTER opened with the ProBeam System from Varian Medical Systems. Treatments will begin in September. The center has two treatment rooms offering image-guided intensity-modulated proton therapy, as well as one room dedicated to research. One treatment room will be devoted to pediatric patients and the other to adult patients.... […]
WASHINGTON UNIVERSITY Siteman Cancer Center received a Specialized Program of Research Excellence five-year grant of $10.4 million to lead a national group of experts in collaborative pancreatic cancer research.
MICHAEL JAN BARTEL joined the Department of Medicine as a gastroenterologist at Fox Chase Cancer Center. Bartel earned his medical degree at Ruprecht-Karls-University Heidelberg in Germany. He completed his residency at Dartmouth-Hitchcock Medical Center in Lebanon, N.H. In 2012, he joined the Department of Gastroenterology and Hepatology at the Mayo Clinic in Jacksonville, Fla., as... […]
